Immutep Limited (ASX:IMM)
Australia · Delayed Price · Currency is AUD 0.0330
-0.0010 (-2.94%)
Oct 1, 2026, 4:11 PM AEST
Immutep Market Cap
Immutep has a market cap or net worth of 48.63 million as of October 1, 2026. Its market cap has decreased by -87.50% in one year.
Market Cap
48.63M
Enterprise Value
-19.19M
Revenue
19.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
ChartMarket Cap Chart
Since August 29, 1996, Immutep's market cap has increased from 3.66M to 48.63M, an increase of 1,227.69%. That is a compound annual growth rate of 8.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 48.63M | -92.05% |
| Dec 31, 2025 | 611.59M | 15.11% |
| Dec 31, 2024 | 531.29M | 29.54% |
| Dec 29, 2023 | 410.15M | 69.62% |
| Dec 30, 2022 | 241.81M | -42.22% |
| Dec 31, 2021 | 418.52M | 55.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 88.28M |
| LTR Pharma | 87.25M |
| Prescient Therapeutics | 75.71M |
| Avecho Biotechnology | 73.41M |
| Entropy Neurodynamics | 65.34M |
| Amplia Therapeutics | 59.03M |
| Neurizon Therapeutics | 58.91M |
| Arovella Therapeutics | 58.02M |